Paul: An NIH foundation holds $1.2 trillion in Big Pharma vaccine revenue
“There's an NIH foundation that has 1.2 trillion dollars in it given from Big Pharma for their share of the COVID vaccine.”
Galloway: Breaking up Big Tech, Pharma, and agriculture is the best anti-inflation fix
“I think the best thing we could do for inflation would be a series of breaking up everything from big chicken and big pharma to big tech.”
Branson says big pharma's scale turns AI into an unstoppable juggernaut
“You're surprised at the amount of time it takes for a message to percolate, but eventually everyone, everyone gets behind it, you know, then you've turned the ocean tank and then it's this unstoppable juggernaut, right? Yeah. Because there's a lot of capital a…”
Ecko: 1990 Big Pharma marketing graduates could start at $65K to $85K
“You could make, like, at that time, and graduating in 1990, 65 to 85,000 dollars, like, right out of school.”
Ramaswamy: Big pharma incentives force employees to only take consensus risks
“People don't take risks unless they're the same risks that the other pharma companies are taking, because if you take the same risk and fail, but everybody else is failing in a therapeutic category at the same time, you're safe. But if you take a risk that oth…”
Chamath: COVID-19 vaccine push was a Big Pharma revenue grab
“It was a revenue grab by big pharma plastered with non-scientific thinking from a bunch of people who should have known better.”
Niedel: Big Pharma opposes Kratom because it treats opioid addiction
“Big Pharma doesn't like Kratom because it helps people get off of opioid addiction.”
Scotti: Americans Blame Big Pharma but Actually Suffer from Big PBMs
“All the time you hear Americans, you know, close to you walking around complaining about Big Pharma, and you, what you hear them complaining about is Big Pharma. What they're actually complaining about that they don't know is Big PBM and Big Pharmacy.”
Cuban: Big pharma will match Cost Plus Drugs' pricing as scale grows
“A lot of them will match. Some of them will ignore us. It depends on how big we get. You know, if we have ten million customers, they'll pay attention to us. If we have a million customers, maybe not. You know, and there'll be times when there'll be PR and, yo…”
Bloom: Psychedelics will fundamentally disrupt and replace psychiatric medications
“Science is starting to show in a meaningful way that psychedelic compounds can be extraordinarily useful for people dealing with depression. I mean, we're gonna, it's gonna completely separate and completely change antidepressants, anti-anxiety medicines, and …”
Biotech Boards Increasingly Retain U.S. Rights and Out-License Ex-U.S. Rights
“What we've seen really over the last 10 years is a lot of boards want the companies to be able to be standalone. And so, what you see are, in this fairly typical and actually Spark is a good example, where the company will keep commercial rights for the U.S. A…”
Kindler: Future pharma innovation will originate outside big pharma incumbents
“I imagine a lot of this Innovation will come outside of big pharma, but the big pharma's that succeed will be the ones that get it.”
Lowe: Tech-bio service pilot models fail to generate sustainable economics
“And they start as a service company. They start by saying, hey, I'm gonna go to big pharma. I have a new techno, technological breakthrough. I'm gonna sell that as a pilot to, as a service to big pharma companies. And then they can't generate the economics tha…”
Bhardwaj: InnoPlexus serves around six major pharmaceutical clients
“So we have around six big pharma clients for various therapeutic areas.”
Bryan Johnson: OS Fund built science investment frameworks using Big Pharma practices
“So we used we went out and analyzed a number of different decision-making processes for Big Pharma and Big Oil, how they actually gather data, process data, and make decisions. So we used decision analysis and created a model that helped guide us through what …”
Mike Driscoll: Big pharma R&D cuts create data science recruiting opportunities
“Most big pharma actually have turned, reduced their investment in R&D, and many of, it's a great place to recruit data scientists is out of these pharma R&D labs.”